Healthcare · Pharmaceuticals & Biotechnology
Aurobindo Pharma Limited is an Indian multinational pharmaceutical manufacturing company based in HITEC City, Hyderabad, with U.S. headquarters in East Windsor, Mercer County, New Jersey. The company manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company's area of activity includes six major therapeutic and product areas: antibiotics, anti-retrovirals, cardiovascular products, central nervous system products, gastroenterologicals, and anti-allergics. The company markets these products in over 125 countries. Its marketing partners include Pfizer and AstraZeneca.
Source: Wikipedia
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 11,759† | 11,290† | 11,262† | 13,254† | 11,941† |
| Net profit | 2,415 | 1,747 | 1,954 | 1,230 | 1,455† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Madan Mohan Reddy Mettu | Executive Director | June 30, 2026 |
| Nithyananda Reddy Kambam | Executive Director | June 30, 2026 |
| Girish Paman Vanvari | Independent Director | June 30, 2026 |
| Mangalam Ramasubramanian Kumar | Independent Director | June 30, 2026 |
| Punita Kumar Sinha | Independent Director | June 30, 2026 |
| Santanu Mukherjee | Independent Director | June 30, 2026 |
| Sarath Chandra Reddy Penaka | Non-Executive Director | June 30, 2026 |
| Satakarni Makkapati | Non-Executive Director | June 30, 2026 |
| Venkata Ramprasad Reddy Penaka | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
